Revance Therapeutics Inc. buy melinda
Start price
21.05.17
/
50%
€18.22
Target price
26.05.17
€20.75
Performance (%)
6.19%
End price
26.05.17
€19.35
Summary
This prediction ended on 26.05.17 with a price of €19.35. With a performance of 6.19%, the BUY prediction by melinda for Revance Therapeutics Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Revance Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 1.851% | 5.158% | 17.711% | 19.954% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% | 56.636% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% | 7.721% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% | 47.507% |
According to melinda what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Revance Therapeutics Inc.
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.40
01.11.21
01.11.21
€15.00
01.11.22
01.11.22
79.03%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.50
28.11.20
28.11.20
€23.00
28.11.21
28.11.21
-36.41%
01.11.21
01.11.21
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.40
09.02.20
09.02.20
-
04.11.21
04.11.21
-20.08%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.04
09.02.20
09.02.20
-
09.02.20
09.02.20
-
09.02.20
09.02.20
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.04
09.02.20
09.02.20
-
09.02.20
09.02.20
-
09.02.20
09.02.20
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€23.40
07.02.20
07.02.20
-
09.02.20
09.02.20
4.27%
09.02.20
09.02.20
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.38
10.05.18
10.05.18
€30.04
08.11.18
08.11.18
-17.74%
08.11.18
08.11.18
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.38
10.05.18
10.05.18
€30.04
10.05.18
10.05.18
0.00%
10.05.18
10.05.18
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.20
21.05.17
21.05.17
€23.00
26.05.17
26.05.17
6.19%
26.05.17
26.05.17
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.47
10.05.16
10.05.16
€17.14
24.05.16
24.05.16
11.20%
24.05.16
24.05.16
Could be worthwhile Investment >10% per year